English
Back
Download
Need Help?
Log in to access Online Inquiry
Back to the Top
Asx traders
commented on a stock · May 13 11:51
$Botanix Pharmaceuticals Ltd (BOT.AU)$ All we need here is ramp us sales figure. atleast 36k for next quarter and 45k prescription in october quarter. It has history of up and down. By any chanse if we can achieve GTN 30% by Q4 we will have revenue of 19.5 million. This could help us to achive breakeven. There is still chanse to upgrade BOT to tier 2 by us insurance companies where we can expect Gtn at around 35% with atleast 20% more sales figure. DYOR.
All we need here is ramp us sales figure. atleast 36k for next quarter and 45k prescription in october quarter. It has history of up and down. By any chanse if we can achieve GTN 30% by Q4 we will have revenue of 19.5 million. This could help us to achive breakeven. There is still chanse to upgrade BOT to tier 2 by us insurance companies where we can expect Gtn at around 35% with atleast 20% more sales figure. DYOR.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.Read more
Thumbs Up
4
9477 Views
Report
Comment (1)
Write a Comment...
1
4